A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer. [electronic resource]
Producer: 20100817Description: 102-7 p. digitalISSN:- 1938-0674
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers, Tumor
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Disease Progression
- Drug Therapy, Combination
- Female
- Fluorouracil -- administration & dosage
- Humans
- Kaplan-Meier Estimate
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins p21(ras)
- Treatment Outcome
- United States
- ras Proteins
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.